Holly J - Search Results

1

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.

Oliver SE, Holly J, Peters TJ, Donovan J, Persad R, Gillatt D, Pearce A, Hamdy FC, Neal DE, Gunnell D. Oliver SE, et al. Among authors: holly j. Urology. 2004 Aug;64(2):317-22. doi: 10.1016/j.urology.2004.03.018. Urology. 2004. PMID: 15302487

2

The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.

Cotterill AM, Holly JM, Taylor AM, Davies SC, Coulson VJ, Preece MA, Wass JA, Savage MO. Cotterill AM, et al. Among authors: holly jm. J Clin Endocrinol Metab. 1992 Jan;74(1):56-63. doi: 10.1210/jcem.74.1.1370165. J Clin Endocrinol Metab. 1992. PMID: 1370165

3

Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.

Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Donaghy A, et al. Among authors: holly j. Hepatology. 1995 Mar;21(3):680-8. Hepatology. 1995. PMID: 7533122

4

Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner.

Gill ZP, Perks CM, Newcomb PV, Holly JM. Gill ZP, et al. Among authors: holly jm. J Biol Chem. 1997 Oct 10;272(41):25602-7. doi: 10.1074/jbc.272.41.25602. J Biol Chem. 1997. PMID: 9325280 Free article.

5

Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn.

Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed-Ali V, Yudkin JS, Wilkinson AR, Dunger DB. Ogilvy-Stuart AL, et al. Among authors: holly jm. J Clin Endocrinol Metab. 1998 Oct;83(10):3550-7. doi: 10.1210/jcem.83.10.5162. J Clin Endocrinol Metab. 1998. PMID: 9768663

6

Leg length and risk of cancer in the Boyd Orr cohort.

Gunnell DJ, Smith GD, Holly JM, Frankel S. Gunnell DJ, et al. Among authors: holly jm. BMJ. 1998 Nov 14;317(7169):1350-1. doi: 10.1136/bmj.317.7169.1350. BMJ. 1998. PMID: 9812931 Free PMC article. No abstract available.

7

Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?

Holly JM, Gunnell DJ, Davey Smith G. Holly JM, et al. J Endocrinol. 1999 Sep;162(3):321-30. doi: 10.1677/joe.0.1620321. J Endocrinol. 1999. PMID: 10467223 Review.

8

Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells.

Williams AC, Collard TJ, Perks CM, Newcomb P, Moorghen M, Holly JM, Paraskeva C. Williams AC, et al. Among authors: holly jm. Cancer Res. 2000 Jan 1;60(1):22-7. Cancer Res. 2000. PMID: 10646845

9

Regulatory mechanisms in prostate cancer.

Jefferson K, Dwivedi A, Persad R, Holly J. Jefferson K, et al. Among authors: holly j. Lancet. 2000 Mar 25;355(9209):1100-1. doi: 10.1016/S0140-6736(05)72223-6. Lancet. 2000. PMID: 10744117 No abstract available.

10

Insulin-like growth factor binding proteins (IGFBPs) in breast cancer.

Perks CM, Holly JM. Perks CM, et al. Among authors: holly jm. J Mammary Gland Biol Neoplasia. 2000 Jan;5(1):75-84. doi: 10.1023/a:1009519400591. J Mammary Gland Biol Neoplasia. 2000. PMID: 10791770 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters